Trial
NCT03120676
Study of Atezolizumab in Relapsed or Refractory Hodgkin Lymphoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
Genentech, Inc.
Condition
Hodgkin Lymphoma
Intervention
Atezolizumab
Why stopped
Lack of accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-11-14